Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Carpi – page 2

19 clinical trials in Carpi, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Carpi at a glance
19
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

19 trials in Carpi

Open in trial search

Study on Avelumab for Patients with High-Risk Triple Negative Breast Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Universita Degli Studi Di Padova

Study of drug combination with gemcitabine, cisplatin, carboplatin and avelumab in patients with advanced urothelial cancer to evaluate response to platinum-based chemotherapy

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Study of Palbociclib as an Alternative to Chemotherapy for Older Patients with High-Risk Early Breast Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:65+ years
  • Substances:Anastrozole
  • Sponsor:European Organisation For Research And Treatment Of Cancer

Study on TAR-200 and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Ineligible for or Refusing Platinum-Based Chemotherapy

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cetrelimab
  • Sponsor:Janssen Cilag International

Bladder cancer

Not recruiting

Study Comparing Chemotherapy Alone to Chemotherapy with Nivolumab or Nivolumab and BMS-986205 for Patients with Muscle-Invasive Bladder Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study of TAR-200 and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Not Undergoing Radical Cystectomy

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cetrelimab
  • Sponsor:Janssen Cilag International

Study of enzalutamide alone versus enzalutamide with radium-223 combination in patients with bone metastatic castration-resistant prostate cancer with mild or no symptoms

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:European Organisation For Research And Treatment Of Cancer

Other cities in Italy

The busiest research cities in the country

All 237 cities in Italy

Clinical research in Carpi

What the registry says about research in the country

01 Obstetrics & Gynecology

Innovative research focusing on premature rupture of membranes and advanced ovarian cancer treatments, including specialized studies for BRCA wild-type patients.

  • Perinatal Management Studies
  • Ovarian Cancer Therapeutics
  • BRCA-Related Research

Multiple trials evaluating maintenance therapies and treatment outcomes for gynecological cancers.

02 Urological Oncology

Comprehensive studies in bladder cancer and prostate cancer treatments, exploring innovative combination therapies and targeted approaches.

  • Muscle-Invasive Bladder Cancer
  • Metastatic Prostate Cancer
  • Advanced Urothelial Cancer

Investigating novel treatment combinations including immunotherapy and radiotherapy approaches.

03 Advanced Cancer Research

Cutting-edge trials in colorectal cancer and small cell lung cancer, with focus on precision medicine and immunotherapy applications.

  • Targeted Therapy Studies
  • Immunotherapy Trials
  • Breast Cancer Research

Evaluation of novel drug combinations and biomarker-driven treatment approaches.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.